Interestingly, RNA-seq analyses of primary liver samples from human NASH patients and healthy controls (GSE134422) showed that MOF was significantly downregulated in human NASH patients (Fig. 4A). Here, KAT8 is linked to metabolic dysfunction-associated steatohepatitis.